NCT01315223

Outpatient Lung Impedance-Guided Preventive Therapy in Patients With Chronic Heart Failure (CHF)

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Hillel Yaffe Medical Center · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients suffering from Chronic Heart Failure (CHF) are hospitalized for acute heart failure (AHF) several times a year. Currently, we have no method for prediction of future developments of AHF. In our center we have investigated the monitoring of lung impedence as a predictor for future deterioration. It was found that a decrease in lung impedence of more than 15% from normal value predicts AHF development with sensitivity of 98%. In this study we try to prove the hypothesis that preventive treatment according to lung impedence value may prevent future hospitalizations for AHF and improve clinical outcome. Patients recruited by year: 2011 - 50; 2012 - 25; 2013 - 35; 2014 - 30; 2015 - 50; 2016 - 5

Conditions

• Chronic Congestive Heart Failure

Interventions

Type	Name	Description
OTHER	Lung impedence-guided treatment	One hundred fifty patients with CHF will be treated according to common practice and values of lung impedance

Timeline

• Start date: 2011-03-01
• Primary completion: 2018-06-01
• Completion: 2018-06-01
• First posted: 2011-03-15
• Last updated: 2016-07-21

Locations

1 site across 1 country: Israel